These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6225866)

  • 1. Pharmacokinetic studies of 5-fluorouracil and 5'-deoxy-5-fluorouridine in rats.
    Au JL; Walker JS; Rustum Y
    J Pharmacol Exp Ther; 1983 Oct; 227(1):174-80. PubMed ID: 6225866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the differential affinities of two anticancer analogues to their target.
    Holl E; Zänker KS; Lange J; Siewert JR
    Drugs Exp Clin Res; 1985; 11(2):133-9. PubMed ID: 2941256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moment analysis of intestinal first-pass metabolism by portal-systemic concentration difference in single conscious rat using 5'-deoxy-5-fluorouridine and 5-fluorouracil as model drug system.
    Sawai Y; Yamaoka K; Takemura A; Nakagawa T
    J Pharm Sci; 1997 Nov; 86(11):1269-72. PubMed ID: 9383738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Measurement of 5'-deoxy-5-fluorouridine (5'-DFUR) by high-performance liquid chromatography and studies on pharmacokinetics of 5'-DFUR and 5-fluorouracil by oral and intravenous administration].
    Hara Y; Kono A; Tanaka M
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2261-6. PubMed ID: 6237614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and availability of 5-fluorouracil prodrug 5'-deoxy-5-fluorouridine after oral administration in rats.
    Au JL
    J Pharm Sci; 1987 Sep; 76(9):699-702. PubMed ID: 11002805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment.
    Hull WE; Port RE; Herrmann R; Britsch B; Kunz W
    Cancer Res; 1988 Mar; 48(6):1680-8. PubMed ID: 3125967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of administration route in the therapeutic efficacy of doxifluridine.
    Trave F; Canobbio L; Au JL; Rustum YM
    J Natl Cancer Inst; 1987 Mar; 78(3):527-32. PubMed ID: 2950266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced antitumor effect of 5'-deoxy-5-fluorouridine by oral administration with L-cysteine.
    Iigo M; Nakajima Y; Araki E; Hoshi A
    Jpn J Cancer Res; 1989 Feb; 80(2):182-7. PubMed ID: 2524459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of 5-fluorouracil and its metabolites in colon cancer patients.
    Casale F; Canaparo R; Serpe L; Muntoni E; Pepa CD; Costa M; Mairone L; Zara GP; Fornari G; Eandi M
    Pharmacol Res; 2004 Aug; 50(2):173-9. PubMed ID: 15177306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression of phenytoin metabolic capacity by 5-fluorouracil and doxifluridine in rats.
    Konishi H; Yoshimoto T; Morita K; Minouchi T; Sato T; Yamaji A
    J Pharm Pharmacol; 2003 Jan; 55(1):143-9. PubMed ID: 12625878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoropyrimidine chemotherapy in a rat model: comparison of fluorouracil metabolite profiles determined by high-field 19F-NMR spectroscopy of tissues ex vivo with therapy response and toxicity for locoregional vs systemic infusion protocols.
    Lutz NW; Naser-Hijazi B; Koroma S; Berger MR; Hull WE
    NMR Biomed; 2004 May; 17(3):101-31. PubMed ID: 15137037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue distribution of 5'-deoxy-5-fluorouridine and derived 5-fluorouracil in tumor-bearing mice and rats.
    Suzuki S; Hongu Y; Fukazawa H; Ichihara S; Shimizu H
    Gan; 1980 Apr; 71(2):238-45. PubMed ID: 6451469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential selectivity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in cultured human B lymphocytes and mouse L1210 leukemia.
    Au JL; Rustum YM; Minowada J; Srivastava BI
    Biochem Pharmacol; 1983 Feb; 32(3):541-6. PubMed ID: 6221728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selectivity of action of 5-FU: biochemical basis.
    Rustum YM; Danhauser L; Wang G
    Bull Cancer; 1979; 66(1):43-7. PubMed ID: 154352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological activities of 5-fluorouracil and its prodrug 5'-deoxy-5-fluorouridine in rats.
    Au JL; Rustum YM; Slocum HK
    Cancer Drug Deliv; 1987; 4(3):137-44. PubMed ID: 2967103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with radiation therapy in mice bearing colon 26 adenocarcinoma.
    Ishikawa T; Tanaka Y; Ishitsuka H; Ohkawa T
    Jpn J Cancer Res; 1989 Jun; 80(6):583-91. PubMed ID: 2527217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5'-deoxy-5-fluorouridine against adenocarcinoma 755 in mice. Correlation with pharmacokinetics of plasma 5-fluorouracil levels.
    Iigo M; Nishikata K; Nakajima Y; Hoshi A; Okudaira N; Odagiri H; De Clercq E
    Biochem Pharmacol; 1989 Jun; 38(12):1885-9. PubMed ID: 2525905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Conversion of 5'-deoxy-5-fluorouridine to 5-FU by pyrimidine nucleoside phosphorylases in normal and tumor tissues from rodents bearing tumors and cancer patients].
    Miwa M; Nishimura J; Kamiyama T; Ishitsuka H
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2924-9. PubMed ID: 2959206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between plasma pharmacokinetics and tissue metabolites of 5-fluorouracil (5-FU) in patients with colorectal cancer.
    Finan PJ; Chisholm EM; Woodhouse L; Giles GR
    Eur J Surg Oncol; 1987 Aug; 13(4):349-53. PubMed ID: 2957234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.